LJUI.F Stock Overview
An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 5/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
SSY Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$0.70 |
| 52 Week High | HK$0.70 |
| 52 Week Low | HK$0.66 |
| Beta | 0.82 |
| 11 Month Change | 0% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | 7.49% |
| 5 Year Change | n/a |
| Change since IPO | 39.74% |
Recent News & Updates
Recent updates
Shareholder Returns
| LJUI.F | US Pharmaceuticals | US Market | |
|---|---|---|---|
| 7D | 0% | -7.0% | -2.1% |
| 1Y | n/a | 8.5% | 29.7% |
Return vs Industry: Insufficient data to determine how LJUI.F performed against the US Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how LJUI.F performed against the US Market.
Price Volatility
| LJUI.F volatility | |
|---|---|
| LJUI.F Average Weekly Movement | n/a |
| Pharmaceuticals Industry Average Movement | 9.7% |
| Market Average Movement | 6.2% |
| 10% most volatile stocks in US Market | 15.6% |
| 10% least volatile stocks in US Market | 3.1% |
Stable Share Price: LJUI.F has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine LJUI.F's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 5,004 | Jiguang Qu | www.ssygroup.com.hk |
SSY Group Limited, an investment holding company, researches, develops, manufactures, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally. The company offers intravenous infusion solutions, including non-PVC soft bags, upright soft bags, PP plastic bottles, and glass bottle infusion solutions, as well as ampoule injections. It also provides small volume injections, oral preparations, Chinese medicine preparations, and biological preparations, as well as bulk pharmaceutical products and medical materials.
SSY Group Limited Fundamentals Summary
| LJUI.F fundamental statistics | |
|---|---|
| Market cap | US$1.65b |
| Earnings (TTM) | US$144.00m |
| Revenue (TTM) | US$825.13m |
11.5x
P/E Ratio2.0x
P/S RatioIs LJUI.F overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| LJUI.F income statement (TTM) | |
|---|---|
| Revenue | HK$6.43b |
| Cost of Revenue | HK$2.87b |
| Gross Profit | HK$3.57b |
| Other Expenses | HK$2.44b |
| Earnings | HK$1.12b |
Last Reported Earnings
Dec 31, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.38 |
| Gross Margin | 55.45% |
| Net Profit Margin | 17.45% |
| Debt/Equity Ratio | 49.0% |
How did LJUI.F perform over the long term?
See historical performance and comparison